Abstract
Several agents have been employed for treatment of hyperuricemia. Allopurinol, an inhibitor of xanthine oxidase (1) is often used as a hypouricemic agents. Benzbromarone, which is reported to have a uricosuric effect (2), has also been employed. It has been recently reported that combination of these two drugs has been favorable in gouty patients (3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kelley WN, Palella TD: Gout and other disorders of purine metabolism. in Braunwaid E, Isselbacher KJ, Petersdorf RG, et al (ed): Harrison’s principles of internal medicine (eleventh ed). New York, McGraw-Hill, 1987, pp 1623-1632
Zollner N, Griebsch A, Fink JK: The effect of benzbromarone on serum uric acid level and uric acid excretion in gouty persons. Dtsch Med Wochenschr 95: 2405–2412, 1970
Mertz DPI: Reducing the risks in the treatment of gout and hyperuricemia. Dtsch Med Wochenschr 101: 1288–1292, 1976
Kaneko K, Fujimori S, Ishizuka I, et al: Effect of ethanol on metabolism of the hypouricemic agents allopurinol and benzbromarone. Clin.Chim.Acta 193:181–186, 1990.
Fujimori S, Nakayama Y, Kaneko K, et al: Contents of purine bases in alcoholic beverages. Uric Acid Research 9: 128–133, 1985
Walter-Sack I, Vries JX, Ittensohn A, et al: Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of denomination to benzarone. Klin Wochenschr 66: 160–166, 1988
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kaneko, K., Fujimori, S., Akaoka, I. (1991). Changes Caused by Ethanol Intake on Metabolism of Hypouricemic Agents (Combination of Allopurinol and Benzbromarone). In: Harkness, R.A., Elion, G.B., Zöllner, N. (eds) Purine and Pyrimidine Metabolism in Man VII. Advances in Experimental Medicine and Biology, vol 309A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2638-8_31
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2638-8_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2640-1
Online ISBN: 978-1-4899-2638-8
eBook Packages: Springer Book Archive